Everest Medicines Ltd
HKEX:1952
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Everest Medicines Ltd
HKEX:1952
|
CN |
|
Borussia Dortmund GmbH & Co KGaA
XETRA:BVB
|
DE |
|
Mining Minerals & Metals PLC
LSE:MMM
|
UK |
|
S4 Capital PLC
LSE:SFOR
|
UK |
|
Regis Corp
NASDAQ:RGS
|
US |
|
Austin Metals Ltd
ASX:AYT
|
AU |
|
UAngel Corp
KRX:072130
|
KR |
|
Sumec Corp Ltd
SSE:600710
|
CN |
|
Sify Technologies Ltd
NASDAQ:SIFY
|
IN |
|
L&T Finance Holdings Ltd
NSE:L&TFH
|
IN |
|
S
|
Silvergate Capital Corp
F:0XZ
|
US |
|
PMV Pharmaceuticals Inc
NASDAQ:PMVP
|
US |
|
Naturgy Energy Group SA
MAD:NTGY
|
ES |
|
J
|
Joinn Laboratories China Co Ltd
SSE:603127
|
CN |
|
GMM Pfaudler Ltd
NSE:GMMPFAUDLR
|
IN |
|
Brunello Cucinelli SpA
MIL:BC
|
IT |
|
Iberdrola SA
MAD:IBE
|
ES |
|
Agung Podomoro Land Tbk PT
IDX:APLN
|
ID |
Bankruptcy Probability
Everest Medicines Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Everest Medicines Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
E
|
Everest Medicines Ltd
HKEX:1952
|
10.6B HKD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
66.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
41.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Everest Medicines Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Everest Medicines Ltd has total debt of 278.3m CNY. This includes both short-term (0 CNY) and long-term (278.3m CNY) debt.
You can find a full breakdown on its Balance Sheet.
